News | June 25, 2024
Sun Pharma completes Taro merger
Combined entity is better positioned to compete in increasingly competitive generics industry
Combined entity is better positioned to compete in increasingly competitive generics industry
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
The Issue opened on June 18, 2024 and closed on June 21, 2024
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
Subscribe To Our Newsletter & Stay Updated
